| Literature DB >> 25843713 |
Clara Penas1, Eve-Ellen Govek2, Yin Fang2, Vimal Ramachandran1, Mark Daniel1, Weiping Wang3, Marie E Maloof1, Ronald J Rahaim4, Mathieu Bibian4, Daisuke Kawauchi5, David Finkelstein6, Jeng-Liang Han4, Jun Long7, Bin Li7, David J Robbins7, Marcos Malumbres8, Martine F Roussel5, William R Roush4, Mary E Hatten2, Nagi G Ayad9.
Abstract
Although casein kinase 1δ (CK1δ) is at the center of multiple signaling pathways, its role in the expansion of CNS progenitor cells is unknown. Using mouse cerebellar granule cell progenitors (GCPs) as a model for brain neurogenesis, we demonstrate that the loss of CK1δ or treatment of GCPs with a highly selective small molecule inhibits GCP expansion. In contrast, CK1δ overexpression increases GCP proliferation. Thus, CK1δ appears to regulate GCP neurogenesis. CK1δ is targeted for proteolysis via the anaphase-promoting complex/cyclosome (APC/C(Cdh1)) ubiquitin ligase, and conditional deletion of the APC/C(Cdh1) activator Cdh1 in cerebellar GCPs results in higher levels of CK1δ. APC/C(Cdh1) also downregulates CK1δ during cell-cycle exit. Therefore, we conclude that APC/C(Cdh1) controls CK1δ levels to balance proliferation and cell-cycle exit in the developing CNS. Similar studies in medulloblastoma cells showed that CK1δ holds promise as a therapeutic target.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25843713 PMCID: PMC4401652 DOI: 10.1016/j.celrep.2015.03.016
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423